FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to medicinal agents and using a mixture of enantiomers of milnacipran enriched with (1S,2R)-enantiomer of milnacepran, and/or at least one of its metabolite. Also, invention relates to their pharmaceutically acceptable salts in treatment or prophylaxis of disorders or state that are regulated by double inhibition of reuptake of serotonin and noreprinephrine and with simultaneous restriction for risk of cardiovascular disorders.
EFFECT: valuable medicinal properties of drug.
24 cl, 7 tbl, 8 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATING PHRENOPATHIES | 2008 |
|
RU2389490C2 |
| CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR PHRENOPATHY TREATMENT | 2003 |
|
RU2356554C2 |
| APPLICATION OF FLECAINIDE AS ANTICONNEXIN AGENT AND METHOD OF POTENTIATION OF EFFECTS OF PSYCHOTROPIC MEDICINES | 2014 |
|
RU2661026C2 |
| NICOTINIC RECEPTOR LIGANDS | 2007 |
|
RU2441007C2 |
| USING CANNABINOIDS COMBINED WITH ANTIPSYCHOTIC DRUG PREPARATION | 2008 |
|
RU2503448C2 |
| 1-PHENYL-2-DIMETHYLAMINOMETHYLCYCLOHEXANE COMPOUNDS FOR DEPRESSION TREATMENT AND PAIN MANAGEMENT | 2003 |
|
RU2387446C2 |
| 1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
| NON-COMPETITIVE NICOTINIC RECEPTOR ANTAGONISTS | 2011 |
|
RU2582339C2 |
| N-OXIDE AND/OR DI-N-OXIDE DERIVATIVES OF STABILISERS/MODULATORS OF DOPAMINE RECEPTORS, DEMONSTRATING IMPROVED PROFILES OF CARDIO-VASCULAR SIDE EFFECTS | 2008 |
|
RU2470013C2 |
| COMBINATIONS CONTAINING ALPHA-2-DELTA LIGANDS AND SEROTONIN/NORADRENALINE REUPTAKE INHIBITORS | 2004 |
|
RU2320369C2 |
